| Roy Ziegelstein, MD | |
|
4940 Eastern Ave, Baltimore, MD 21224-2735 | |
| (410) 550-4642 | |
| Not Available |
| Full Name | Roy Ziegelstein |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 4940 Eastern Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700812096 | NPI | - | NPPES |
| 535241000 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D38461 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
The shortage of primary care doctors could worsen if funding for the Teaching Health Centers, a program to train medical residents in underserved areas, is eliminated. Loss of funding - which has already been drastically reduced - could disrupt the training of 550 current medical residents and cut off the pipeline of future primary care residents, says a new report conducted by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at Milken Institute School of Public Health at the George Washington University.
New research in Respirology shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day.
Testing Millions,' a groundbreaking global effort led by AIDS Healthcare Foundation to test millions of people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more than 4.2 million people for HIV and identifying more than 110,106 HIV-positive individuals in 23 countries around the world.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
The shortage of primary care doctors could worsen if funding for the Teaching Health Centers, a program to train medical residents in underserved areas, is eliminated. Loss of funding - which has already been drastically reduced - could disrupt the training of 550 current medical residents and cut off the pipeline of future primary care residents, says a new report conducted by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at Milken Institute School of Public Health at the George Washington University.
New research in Respirology shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day.
Testing Millions,' a groundbreaking global effort led by AIDS Healthcare Foundation to test millions of people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more than 4.2 million people for HIV and identifying more than 110,106 HIV-positive individuals in 23 countries around the world.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roy Ziegelstein, MD Po Box 64250, Baltimore, MD 21264-4250 Ph: (410) 550-4642 | Roy Ziegelstein, MD 4940 Eastern Ave, Baltimore, MD 21224-2735 Ph: (410) 550-4642 |
News Archive
The shortage of primary care doctors could worsen if funding for the Teaching Health Centers, a program to train medical residents in underserved areas, is eliminated. Loss of funding - which has already been drastically reduced - could disrupt the training of 550 current medical residents and cut off the pipeline of future primary care residents, says a new report conducted by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at Milken Institute School of Public Health at the George Washington University.
New research in Respirology shows that suffers of Chronic obstructive pulmonary disease (COPD) can reduce their risk of being hospitalized with severe attacks, by maintaining an exercise regime of walking between three to six kilometers a day.
Testing Millions,' a groundbreaking global effort led by AIDS Healthcare Foundation to test millions of people for HIV as part of a global testing campaign tied to the recent observance of World AIDS Day (December 1st) has far surpassed its goal by testing more than 4.2 million people for HIV and identifying more than 110,106 HIV-positive individuals in 23 countries around the world.
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, announced today that the Spanish Agency of Drugs and Medical Devices (Agencia Espanola de Medicamentos y Productos Sanitarios) granted marketing authorization to ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 4 days ago
Dr. Leonard Anang Sowah, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |